Viatris Aims To Clear Up Investor ‘Disappointment’ After Breaking EBITDA Baseline

Company Also Reiterates $9bn Pre-Tax Proceeds Goal Via Divestments

 
• By Dean Rudge
  
Clock_Stock_Buyback
"Everything else" is competing with share buybacks • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business